Gene expression profile association with poor prognosis in epithelial ovarian cancer patients
Abstract Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management either lack specificity or are very costly. Gene expression profiling has shown to be a very effective tool in exploring new molecular...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad7576e2e7204848a35416de869b709c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:ad7576e2e7204848a35416de869b709c |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:ad7576e2e7204848a35416de869b709c2021-12-02T13:34:46ZGene expression profile association with poor prognosis in epithelial ovarian cancer patients10.1038/s41598-021-84953-92045-2322https://doaj.org/article/ad7576e2e7204848a35416de869b709c2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-84953-9https://doaj.org/toc/2045-2322Abstract Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management either lack specificity or are very costly. Gene expression profiling has shown to be a very effective tool in exploring new molecular markers for patients with OC, although association of such markers with patient survival and clinical outcome is still elusive. Here, we performed gene expression profiling of different subtypes of OC to evaluate its association with patient overall survival (OS) and aggressive forms of the disease. By global mRNA microarray profiling in a total of 196 epithelial OC patients (161 serous, 15 endometrioid, 11 mucinous, and 9 clear cell carcinomas), we found four candidates—HSPA1A, CD99, RAB3A and POM121L9P, which associated with OS and poor clinicopathological features. The overexpression of all combined was correlated with shorter OS and progression-free survival (PFS). Furthermore, the combination of at least two markers were further associated with advanced grade, chemotherapy resistance, and progressive disease. These results indicate that a panel comprised of a few predictors that associates with a more aggressive form of OC may be clinically relevant, presenting a better performance than one marker alone.Douglas V. N. P. OliveiraKira P. PrahmIb J. ChristensenAnker HansenClaus K. HøgdallEstrid V. HøgdallNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Douglas V. N. P. Oliveira Kira P. Prahm Ib J. Christensen Anker Hansen Claus K. Høgdall Estrid V. Høgdall Gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
description |
Abstract Ovarian cancer (OC) is the eighth most common type of cancer for women worldwide. The current diagnostic and prognostic routine available for OC management either lack specificity or are very costly. Gene expression profiling has shown to be a very effective tool in exploring new molecular markers for patients with OC, although association of such markers with patient survival and clinical outcome is still elusive. Here, we performed gene expression profiling of different subtypes of OC to evaluate its association with patient overall survival (OS) and aggressive forms of the disease. By global mRNA microarray profiling in a total of 196 epithelial OC patients (161 serous, 15 endometrioid, 11 mucinous, and 9 clear cell carcinomas), we found four candidates—HSPA1A, CD99, RAB3A and POM121L9P, which associated with OS and poor clinicopathological features. The overexpression of all combined was correlated with shorter OS and progression-free survival (PFS). Furthermore, the combination of at least two markers were further associated with advanced grade, chemotherapy resistance, and progressive disease. These results indicate that a panel comprised of a few predictors that associates with a more aggressive form of OC may be clinically relevant, presenting a better performance than one marker alone. |
format |
article |
author |
Douglas V. N. P. Oliveira Kira P. Prahm Ib J. Christensen Anker Hansen Claus K. Høgdall Estrid V. Høgdall |
author_facet |
Douglas V. N. P. Oliveira Kira P. Prahm Ib J. Christensen Anker Hansen Claus K. Høgdall Estrid V. Høgdall |
author_sort |
Douglas V. N. P. Oliveira |
title |
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
title_short |
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
title_full |
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
title_fullStr |
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
title_full_unstemmed |
Gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
title_sort |
gene expression profile association with poor prognosis in epithelial ovarian cancer patients |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/ad7576e2e7204848a35416de869b709c |
work_keys_str_mv |
AT douglasvnpoliveira geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients AT kirapprahm geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients AT ibjchristensen geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients AT ankerhansen geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients AT clauskhøgdall geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients AT estridvhøgdall geneexpressionprofileassociationwithpoorprognosisinepithelialovariancancerpatients |
_version_ |
1718392756780400640 |